Brexit: What will it mean for the regulation of medicines?

What are the implications for the movement of medicines from and into the UK, post-brexit? Mark Quick, executive vice president of corporate development at Recipharm, comments on the current situation and the potential implications of the UK exiting the European Union (EU).

The five key areas to drive growth of UK’s pharmaceutical sector

These 5 things are what pharmaceutical companies should be focusing on to maximise their growth in the UK.

The NHS is 70 – Claudia Rubin asks: what’s next?

From birthday teas to big policy, blood donor drives to special 10p coins, the 70th anniversary of the creation of the NHS is getting...

It’s time for a greater role for pharmacists in asthma management

I’ve returned from a Saturday morning in community pharmacy practice and am reflecting on the number of patients I saw with asthma. I checked...

Beyond politics; patient groups and the art of influence

“What is a patient group?”, a friend of mine enquired during one of our recent regular political discussions. It struck me afterwards that given...

The real cost of over the counter prescriptions

  NHS England recently published its guidance for CCGs on the over the counter (OTC) items which should not be routinely prescribed in primary care...

David wants understanding between NHS & industry

Not who you say I am: Pharma companies need to be clear who they’re talking to and why they’re talking to them. Last week a pharma...

Two takes: Bad habits – help or hindrance?

  In this month’s emotive opinion battle, we ask two healthcare professionals if we should be encouraging patients to evaluate their lifestyle choices, or are...

Pharmacists are the last step between HCPs and patients

Having the right medicine at the right time and administered in the right way can be the difference between that patient continuing their treatment...

AI is launching healthcare into the future

With tales of Victorian era conditions on hospital wards, chronic ambulance queues and surgery delays reminiscent of the NHS’s nadir in the early 1990s,...

Latest articles

Brands by numbers: Launch excellence in an increasingly specialised world

As the focus turns to specialist therapy areas and competition increases, achieving a successful launch is becoming even more challenging.

Implementing the national brand strategy at local level

National brand messages for general biological medicines must be tailored to patients and clinicians at a local level, and dovetailed with the needs, priorities...

Pharmaceutical job opportunities: Star recruits for ground-breaking product launch

Star, the UK's first choice outsourcing and resourcing provider to the pharmaceutical, medical device and healthcare industries is delighted to announce a new partnership. Through...